A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

Astellas’ menopause treatment has been accepted for FDA review, five months after the therapy hit a speed bump in a phase 3 trial conducted in Asia.